Table 1.

Demographic Characteristics and State-Trait Anxiety Inventory Scores of Patients Receiving Subcutaneous Immunotherapy and Their Parents

Characteristic	Continued SCIT, adherent (n = 39)	Continued SCIT, nonadherent (n = 23)	Discontinued SCIT (n = 16)	P valuea (adherent vs nonadherent)	P valueb (continued vs discontinued)
Patient sex, n (%)
Female	24 (61.5)	14 (60.8)	11 (68.7)	.85	.58
Male	15 (38.5)	9 (39.2)	5 (31.3)
Patient age (y)
Mean ± SD	14.4 ± 3.6	15.5 ± 3.38	14.9 ± 3.32	.25	.90
Parental age (y)
Mean ± SD	42.5 ± 5.8	43.35 ± 6.65	NA	.63	—
Phase of SCIT, n (%)
Build-up phase	16 (41)	0 (0)	10 (62.5)	<.001	.006
Maintenance phase	23(59)	23 (100)	6 (37.5)
Patient state anxiety score
Mean ± SD	33.24 ± 7.08	35.5 ± 8.38	NA	.33	—
Patient trait anxiety score
Mean ± SD	34.39 ± 7.38	39.5 ± 8.5	NA	.02	—
Parental state anxiety score
Mean ± SD	36.89 ± 9.86	39.11 ± 8.10	NA	.40	—
Parental trait anxiety score
Mean ± SD	40.37 ± 7.87	42.84 ± 7.47	NA	.26	—

Abbreviations: NA, not applicable; SCIT, subcutaneous immunotherapy.

^aP values in the 5th column refer to the comparisons between adherent and nonadherent patients using the chi square and student t-test.

^bP values in the last column refer to the comparisons between continued and discontinued patients using the chi square and student t-test.